Related Experiment Video
Updated: May 14, 2025

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
Published on: May 15, 2020
Development and validation of a clinical prediction tool for non-receipt of updated COVID-19 vaccines
Katia J Bruxvoort1, Lina S Sy2, Richard Contreras2
1Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL 35233, United States; Department of Research & Evaluation, Kaiser Permanente Southern California, 100 S. Los Robles Ave, 5th Floor, Pasadena, CA 91101, United States.
Abstract:
Vaccination with updated COVID-19 vaccines is important to maintain protection against circulating SARS-CoV-2 variants. We developed and validated a prediction model for non-receipt of updated COVID-19 vaccines at Kaiser Permanente Southern California. Of 3,287,287 adults, 20.2 % received 2023-2024 COVID-19 vaccine. We assessed the association of 15 variables available in electronic health records with non-receipt of 2023-2024 updated COVID-19 vaccine. The cohort was split into development and validation samples. Performance of the 15-variable model in the development sample was moderate, with a scaled Brier score of 35.6 %, R2 of 29.3 %, C-statistic of 0.882, discrimination slope of 0.354, and calibration slope of 1; performance was similar for the validation sample and simplified 6-variable and 2-variable models. The strongest predictors were prior non-receipt of bivalent COVID-19 vaccine or influenza vaccine. These results suggest that a simple model using variables available to healthcare providers can be optimized to guide intervention strategies for updated COVID-19 vaccines.
Related Concept Videos
Sensitivity, Specificity, and Predicted Value
Sensitivity is the...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

